Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma
Purpose Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biolog...
Saved in:
Published in | Cellular oncology (Dordrecht) Vol. 44; no. 6; pp. 1351 - 1361 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.12.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose
Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA.
Methods
The mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression.
Results
We found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA (
p
= 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients (
p
= 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues (
p
< 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki‐67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels.
Conclusions
Our data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway. |
---|---|
AbstractList | PurposeCholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA.MethodsThe mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression.ResultsWe found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA (p = 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients (p = 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues (p < 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki‐67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels.ConclusionsOur data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway. Purpose Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA. Methods The mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression. Results We found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA ( p = 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients ( p = 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues ( p < 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki‐67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels. Conclusions Our data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway. Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA.PURPOSECholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA.The mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression.METHODSThe mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression.We found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA (p = 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients (p = 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues (p < 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki-67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels.RESULTSWe found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA (p = 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients (p = 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues (p < 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki-67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels.Our data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway.CONCLUSIONSOur data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway. Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of calcium-activated chloride channels, which have several biological functions. Here, we aimed to investigate the expression and biological function of TTYH3 in CCA. The mRNA and protein expression levels of TTYH3 were investigated in primary human CCA tissues and normal tissues. The DNA methylation levels of three CpG sites in the TTYH3 promoter region were evaluated using pyrosequencing. The effect of TTYH3 expression on proliferation, apoptosis, migration and invasion were assessed in HUCCT1 and QBC939 cells. Xenograft models were developed to substantiate its role in the development of CCA. Western blot analysis was used to investigate the mechanistic role of TTYH3 in regulating CCA progression. We found that TTYH3 was highly expressed both at the mRNA and protein levels in CCA (p = 0.0001) and that the expression levels were significantly related to a poor overall survival of the patients (p = 0.0019). The DNA methylation levels of three CpG sites in the TTYH3 promoter region were significantly lower in CCA tissues compared to normal tissues (p < 0.05). In vitro studies indicated that TTYH3 can promote the proliferation, migration and invasion of the CCA cells. TTYH3 overexpression significantly promoted tumor progression and cellular proliferation in vivo as indicated by Ki-67 expression. In addition, we found that exogenous TTYH3 overexpression induced epithelial-mesenchymal transition (EMT) in CCA as indicated by expression changes in E-cadherin, N-cadherin and vimentin. The EMT process was found to occur through the Wnt/β-catenin signaling pathway, with simultaneous changes in P-GSK3β and β-catenin levels. Our data indicate that DNA hypomethylation-induced overexpression of TTYH3 regulates CCA development and metastasis through the Wnt/β-catenin pathway. |
Author | Dong, Bingzi Zhao, Yanjie Yang, Chenyu Xie, Yuwei Niu, Zhaojian Xue, Weijie Zhu, Chengzhan Wang, Yixiu |
Author_xml | – sequence: 1 givenname: Weijie surname: Xue fullname: Xue, Weijie organization: Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University – sequence: 2 givenname: Bingzi surname: Dong fullname: Dong, Bingzi organization: Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University – sequence: 3 givenname: Yanjie surname: Zhao fullname: Zhao, Yanjie organization: School of Public Health, Qingdao University – sequence: 4 givenname: Yixiu surname: Wang fullname: Wang, Yixiu organization: Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University – sequence: 5 givenname: Chenyu surname: Yang fullname: Yang, Chenyu organization: Department of Pediatric Surgery, The Affiliated Hospital of Qingdao University – sequence: 6 givenname: Yuwei surname: Xie fullname: Xie, Yuwei organization: Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University – sequence: 7 givenname: Zhaojian surname: Niu fullname: Niu, Zhaojian email: nzj532@126.com organization: Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University – sequence: 8 givenname: Chengzhan orcidid: 0000-0002-2775-5863 surname: Zhu fullname: Zhu, Chengzhan email: zhuchengz@qduhospital.cn organization: Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34796468$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9uFSEYxYmpsbX2BVwYEjdusPwbZliaRq1JEze3Ma4IwzAzNAyMwCz6GH0VH8Rnkt7batJF2UDgd04-znkNjkIMFoC3BH8kGLfnmTCOKcKUIIwFp0i-ACeUEoIYZ-Lo35l2x-As5xtcFxdENOIVOGa8lYKL7gTcXa_JTpvXxcUA4wh3u5-XDK4pLrHYDO3qymy90x6ViBabbTDz7aI9LEmH7PayMqe4TTP8Ecr5n9_I6GKDCzC7KWjvwgR1GKALs-tdyVCvcS0xu1yvoJmj12Fy0ehkXIiLfgNejtpne_awn4LrL593F5fo6vvXbxefrpBhbVOQEA1uhxHTRtLB4GHoZS_HRmjKSQ1oEGNXH03DTW86iTm2LRtILzGVWjQtZafgw8G3_vXXZnNRi8vG-jqOjVtW1ViSjnUtqej7J-hN3FL9W6UEbhmtfrJS7x6orV_soNbkFp1u1WPYFegOgEkx52RHZVzZB1-zdF4RrO6rVYdqVa1W7atV9970ifTR_VkRO4hyhcNk0_-xn1H9BWaDuAs |
CitedBy_id | crossref_primary_10_1155_2021_1452801 crossref_primary_10_3389_fonc_2023_1171098 crossref_primary_10_12677_acm_2024_1451622 crossref_primary_10_2139_ssrn_4102957 crossref_primary_10_1007_s12672_024_01281_w crossref_primary_10_4236_abcr_2022_112012 crossref_primary_10_1016_j_tranon_2024_101911 crossref_primary_10_1016_j_archoralbio_2024_106028 crossref_primary_10_1038_s44276_023_00007_9 crossref_primary_10_1109_JBHI_2023_3326485 crossref_primary_10_1155_2022_4201283 crossref_primary_10_1186_s13008_024_00137_7 crossref_primary_10_1016_j_pharmthera_2022_108334 crossref_primary_10_1186_s12935_023_03065_8 crossref_primary_10_2139_ssrn_4102961 crossref_primary_10_3389_fonc_2024_1334592 crossref_primary_10_3389_fgene_2022_1088230 crossref_primary_10_1186_s12885_024_11943_1 crossref_primary_10_1186_s12885_024_11882_x crossref_primary_10_1186_s13018_023_04214_5 crossref_primary_10_3389_fsurg_2022_1057496 crossref_primary_10_1007_s10528_024_10830_5 crossref_primary_10_1186_s13018_023_03919_x crossref_primary_10_3350_cmh_2022_0058 crossref_primary_10_3390_ijms25010289 crossref_primary_10_1016_j_yexmp_2022_104832 crossref_primary_10_1016_j_ejphar_2023_175781 crossref_primary_10_1016_j_intimp_2022_108999 crossref_primary_10_1186_s12876_023_02911_3 crossref_primary_10_1177_15330338221109646 crossref_primary_10_1007_s00432_024_05756_9 crossref_primary_10_1016_j_dld_2023_08_050 crossref_primary_10_1186_s13287_024_03632_4 crossref_primary_10_1002_mco2_576 crossref_primary_10_1080_07357907_2024_2395014 |
Cites_doi | 10.1006/geno.2001.6629 10.1158/0008-5472.CAN-12-0475-T 10.1016/j.gep.2014.12.002 10.1016/j.cell.2016.01.009 10.1523/JNEUROSCI.3532-16.2017 10.1038/sj.onc.1209203 10.1016/S0002-9440(10)63279-8 10.1016/j.bbrc.2003.07.004 10.1016/j.cell.2016.02.024 10.1038/s41388-019-0806-6 10.1038/nature07313 10.1007/s10147-020-01653-6 10.1002/jcp.25797 10.1111/j.1471-4159.2010.07023.x 10.1186/s13046-017-0499-z 10.1038/ng.2849 10.1513/pats.2306010 10.1152/physrev.00016.2004 10.1186/s12943-017-0720-x 10.1038/onc.2011.392 10.1186/s12964-017-0192-z 10.1016/j.bbrc.2019.06.047 10.1111/j.1471-4159.2006.04237.x 10.1002/cphy.c110017 10.1038/modpathol.2012.57 10.3748/wjg.v13.i19.2717 10.1159/000066250 10.1038/s41419-018-0768-6 10.1038/s41575-020-0310-z 10.15252/embr.201745472 10.3390/jcm8111762 10.1016/j.cell.2016.06.028 |
ContentType | Journal Article |
Copyright | Springer Nature Switzerland AG 2021 2021. Springer Nature Switzerland AG. Springer Nature Switzerland AG 2021. |
Copyright_xml | – notice: Springer Nature Switzerland AG 2021 – notice: 2021. Springer Nature Switzerland AG. – notice: Springer Nature Switzerland AG 2021. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1007/s13402-021-00642-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2211-3436 |
EndPage | 1361 |
ExternalDocumentID | 34796468 10_1007_s13402_021_00642_9 |
Genre | Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 81600490 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: taishan scholar foundation of shandong province grantid: 2019010668 funderid: http://dx.doi.org/10.13039/100012620 – fundername: shandong higher education young science and technology support program grantid: 2020KJL005 – fundername: postdoctoral research foundation of china grantid: 2016M602098 funderid: http://dx.doi.org/10.13039/501100010031 – fundername: qingdao postdoctoral science foundation grantid: 2016046 – fundername: National Natural Science Foundation of China grantid: 81600490 – fundername: postdoctoral research foundation of china grantid: 2016M602098 – fundername: taishan scholar foundation of shandong province grantid: 2019010668 |
GroupedDBID | --- -EM 06D 0R~ 0VY 203 29~ 2KG 2KM 2VQ 30V 4.4 406 408 53G 67N 8UJ 96X AAAVM AACDK AAHNG AAIAL AAJBT AAJKR AAJSJ AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAYIU AAYQN AAYTO AAYZH AAZMS ABAKF ABDBF ABDZT ABECU ABFTV ABIPD ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABXPI ACAOD ACGFS ACHSB ACKNC ACMDZ ACMLO ACOKC ACPIV ACPRK ACUHS ACULB ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AOCGG AXYYD BGNMA C6C CSCUP DDRTE DNIVK DPUIP EAD EAP EBD EBLON EBS EIOEI EJD EMB EMK EMOBN EPL ESBYG ESX F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HMJXF HRMNR HZ~ I0C IKXTQ IMOTQ ITM IWAJR J-C JBSCW JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O93 O9J P2P PT4 R9I RLLFE ROL RSV S3A S3B SBL SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 TSG TUS U2A U9L UG4 UOJIU UTJUX UZXMN VFIZW W48 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABEEZ ABFSG ACSTC AEZWR AFDZB AFGXO AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c375t-66507df02592dc0ddb9b9f56a241100d6f8f02c54cbc89040e73d1b9029a65723 |
IEDL.DBID | U2A |
ISSN | 2211-3428 2211-3436 |
IngestDate | Mon Jul 21 09:59:21 EDT 2025 Fri Jul 25 09:56:51 EDT 2025 Thu Apr 03 07:03:57 EDT 2025 Thu Apr 24 23:08:46 EDT 2025 Tue Jul 01 04:25:01 EDT 2025 Fri Feb 21 02:47:51 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Epithelial-mesenchymal transition TTYH3 Migration Wnt/β-catenin DNA methylation Proliferation Cholangiocarcinoma |
Language | English |
License | 2021. Springer Nature Switzerland AG. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-66507df02592dc0ddb9b9f56a241100d6f8f02c54cbc89040e73d1b9029a65723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2775-5863 |
PMID | 34796468 |
PQID | 2607325729 |
PQPubID | 2044311 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2599183871 proquest_journals_2607325729 pubmed_primary_34796468 crossref_citationtrail_10_1007_s13402_021_00642_9 crossref_primary_10_1007_s13402_021_00642_9 springer_journals_10_1007_s13402_021_00642_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-01 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationTitle | Cellular oncology (Dordrecht) |
PublicationTitleAbbrev | Cell Oncol |
PublicationTitleAlternate | Cell Oncol (Dordr) |
PublicationYear | 2021 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Ferrera, Zegarra-Moran, Galietta (CR2) 2011; 1 Eggermont (CR5) 2004; 1 Loewen, Forsyth (CR9) 2005; 85 Walia, Yu, Cao, Sun, McLean, Hollier, Cheng, Mani, Rao, Premkumar, Elble (CR22) 2012; 31 Banales, Marin, Lamarca, Rodrigues, Khan, Roberts, Cardinale, Carpino, Andersen, Braconi, Calvisi, Perugorria, Fabris, Boulter, Macias, Gaudio, Alvaro, Gradilone, Strazzabosco, Marzioni, Coulouarn, Fouassier, Raggi, Invernizzi, Mertens, Moncsek, Rizvi, Heimbach, Koerkamp, Bruix, Forner, Bridgewater, Valle, Gores (CR1) 2020; 17 Jung, Osswald, Blaes, Wiestler, Sahm, Schmenger, Solecki, Deumelandt, Kurz, Xie, Weil, Heil, Thome, Gommel, Syed, Haring, Huber, Heiland, Platten, von Deimling, Wick, Winkler (CR13) 2017; 37 CR17 Kleinman, Gerges, Papillon-Cavanagh, Sin-Chan, Pramatarova, Quang, Adoue, Busche, Caron, Djambazian, Bemmo, Fontebasso, Spence, Schwartzentruber, Albrecht, Hauser, Garami, Klekner, Bognar, Montes, Staffa, Montpetit, Berube, Zakrzewska, Zakrzewski, Liberski, Dong, Siegel, Duchaine, Perotti, Fleming, Faury, Remke, Gallo, Dirks, Taylor, Sladek, Pastinen, Chan, Huang, Majewski, Jabado (CR14) 2014; 46 Yu, Zhang, Wang, Li, Yang, Yan, He, Ji, Miao (CR26) 2018; 9 Chen, You, Jiang, Wang (CR30) 2017; 232 Wohlrab, Markwardt (CR11) 1999; 12 Li, Hu, Zhou, Huang, Peng, Yuan, Yu, Zheng (CR25) 2017; 15 Gupta, Maitra (CR28) 2016; 164 Toiyama, Mizoguchi, Kimura, Hiro, Inoue, Tutumi, Miki, Kusunoki (CR19) 2007; 13 Cao, Liu, Ji, Liu, He, Zhang, Wang (CR31) 2017; 36 Halleran, Sehdev, Rabe, Huyck, Williams, Saha (CR12) 2015; 17 Chenevert, Duvvuri, Chiosea, Dacic, Cieply, Kim, Shiwarski, Seethala (CR24) 2012; 25 Kim, Kang, Lee (CR10) 2003; 309 Yang, Cho, Koo, Tak, Cho, Shim, Park, Lee, Lee, Kim, Raouf, Shin, Oh (CR4) 2008; 455 Duvvuri, Shiwarski, Xiao, Bertrand, Huang, Edinger, Rock, Harfe, Henson, Kunzelmann, Schreiber, Seethala, Egloff, Chen, Lui, Grandis, Gollin (CR6) 2012; 72 Matthews, Shaw, Hooper, Young, Crouch, Campbell (CR16) 2007; 100 Moon, Bae, Jeong, Cho, Hwang (CR20) 2019; 516 CR27 Wang, Zou, Ma, Yu, Wu, Wei, Xiao (CR3) 2017; 16 Carles, Millon, Cromer, Ganguli, Lemaire, Young, Wasylyk, Muller, Schultz, Rabouel, Dembele, Zhao, Marchal, Ducray, Bracco, Abecassis, Poch, Wasylyk (CR7) 2006; 25 Stefaniuk, Swiech, Dzwonek, Lukasiuk (CR15) 2010; 115 Zhang, Liu, Han, Cui, Peng, Xing (CR8) 2020; 25 CR21 West, Corless, Chen, Rubin, Subramanian, Montgomery, Zhu, Ball, Nielsen, Patel, Goldblum, Brown, Heinrich, van de Rijn (CR23) 2004; 165 Rae, Hooper, Eyre, Sutherland, Nicol, Clements (CR18) 2001; 77 Zhou, Li, Li, Zhang, Liu, Yao, Li (CR32) 2019; 38 David, Huang, Chen, Su, Zou, Bardeesy, Iacobuzio-Donahue, Massague (CR29) 2016; 164 AD Halleran (642_CR12) 2015; 17 CL Kleinman (642_CR14) 2014; 46 U Duvvuri (642_CR6) 2012; 72 H Wang (642_CR3) 2017; 16 JM Banales (642_CR1) 2020; 17 DK Moon (642_CR20) 2019; 516 X Li (642_CR25) 2017; 15 ME Loewen (642_CR9) 2005; 85 S Gupta (642_CR28) 2016; 164 E Jung (642_CR13) 2017; 37 P Zhou (642_CR32) 2019; 38 CJ David (642_CR29) 2016; 164 J Chenevert (642_CR24) 2012; 25 Y Yu (642_CR26) 2018; 9 T Chen (642_CR30) 2017; 232 J Eggermont (642_CR5) 2004; 1 Y Toiyama (642_CR19) 2007; 13 Q Cao (642_CR31) 2017; 36 642_CR21 YD Yang (642_CR4) 2008; 455 FK Rae (642_CR18) 2001; 77 642_CR27 642_CR17 RB West (642_CR23) 2004; 165 C Zhang (642_CR8) 2020; 25 JA Kim (642_CR10) 2003; 309 V Walia (642_CR22) 2012; 31 A Carles (642_CR7) 2006; 25 D Wohlrab (642_CR11) 1999; 12 CA Matthews (642_CR16) 2007; 100 L Ferrera (642_CR2) 2011; 1 M Stefaniuk (642_CR15) 2010; 115 |
References_xml | – volume: 77 start-page: 200 year: 2001 end-page: 207 ident: CR18 article-title: TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is located on 17q24 and upregulated in renal cell carcinoma publication-title: Genomics doi: 10.1006/geno.2001.6629 – volume: 72 start-page: 3270 year: 2012 end-page: 3281 ident: CR6 article-title: TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-0475-T – volume: 17 start-page: 38 year: 2015 end-page: 44 ident: CR12 article-title: Characterization of tweety gene (ttyh1-3) expression in Xenopus laevis during embryonic development publication-title: Gene Expr. Patterns doi: 10.1016/j.gep.2014.12.002 – volume: 164 start-page: 1015 year: 2016 end-page: 1030 ident: CR29 article-title: TGF-beta tumor suppression through a lethal EMT publication-title: Cell doi: 10.1016/j.cell.2016.01.009 – volume: 37 start-page: 6837 year: 2017 end-page: 6850 ident: CR13 article-title: Tweety-Homolog 1 drives brain colonization of gliomas publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3532-16.2017 – volume: 25 start-page: 1821 year: 2006 end-page: 1831 ident: CR7 article-title: Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display publication-title: Oncogene doi: 10.1038/sj.onc.1209203 – volume: 165 start-page: 107 year: 2004 end-page: 113 ident: CR23 article-title: The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63279-8 – volume: 309 start-page: 291 year: 2003 end-page: 297 ident: CR10 article-title: Role of Ca2+-activated Cl- channels in the mechanism of apoptosis induced by cyclosporin A in a human hepatoma cell line publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.07.004 – volume: 164 start-page: 840 year: 2016 end-page: 842 ident: CR28 article-title: Matter of life or death? publication-title: Cell doi: 10.1016/j.cell.2016.02.024 – volume: 38 start-page: 5500 year: 2019 end-page: 5515 ident: CR32 article-title: NMIIA promotes tumor growth and metastasis by activating the Wnt/beta-catenin signaling pathway and EMT in pancreatic cancer publication-title: Oncogene doi: 10.1038/s41388-019-0806-6 – volume: 455 start-page: 1210 year: 2008 end-page: 1215 ident: CR4 article-title: TMEM16A confers receptor-activated calcium-dependent chloride conductance publication-title: Nature doi: 10.1038/nature07313 – volume: 25 start-page: 1145 year: 2020 end-page: 1154 ident: CR8 article-title: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma publication-title: Int. J. Clin. Oncol. doi: 10.1007/s10147-020-01653-6 – ident: CR27 – volume: 232 start-page: 3261 year: 2017 end-page: 3272 ident: CR30 article-title: Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis publication-title: J. Cell. Physiol. doi: 10.1002/jcp.25797 – volume: 115 start-page: 1183 year: 2010 end-page: 1194 ident: CR15 article-title: Expression of Ttyh1, a member of the Tweety family in neurons in vitro and in vivo and its potential role in brain pathology publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2010.07023.x – volume: 36 start-page: 29 year: 2017 ident: CR31 article-title: MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-017-0499-z – volume: 46 start-page: 39 year: 2014 end-page: 44 ident: CR14 article-title: Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR publication-title: Nat. Genet. doi: 10.1038/ng.2849 – ident: CR21 – volume: 1 start-page: 22 year: 2004 end-page: 27 ident: CR5 article-title: Calcium-activated chloride channels: (un)known, (un)loved? publication-title: Proc. Am. Thorac. Soc. doi: 10.1513/pats.2306010 – volume: 85 start-page: 1061 year: 2005 end-page: 1092 ident: CR9 article-title: Structure and function of CLCA proteins publication-title: Physiol. Rev. doi: 10.1152/physrev.00016.2004 – volume: 16 start-page: 152 year: 2017 ident: CR3 article-title: Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer publication-title: Mol. Cancer doi: 10.1186/s12943-017-0720-x – ident: CR17 – volume: 31 start-page: 2237 year: 2012 end-page: 2246 ident: CR22 article-title: Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis publication-title: Oncogene doi: 10.1038/onc.2011.392 – volume: 15 start-page: 38 year: 2017 ident: CR25 article-title: CLCA1 suppresses colorectal cancer aggressiveness via inhibition of the Wnt/beta-catenin signaling pathway publication-title: Cell Commun. Signal doi: 10.1186/s12964-017-0192-z – volume: 516 start-page: 521 year: 2019 end-page: 525 ident: CR20 article-title: Upregulated TTYH2 expression is critical for the invasion and migration of U2OS human osteosarcoma cell lines publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2019.06.047 – volume: 100 start-page: 693 year: 2007 end-page: 707 ident: CR16 article-title: Expression and evolution of the mammalian brain gene Ttyh1 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2006.04237.x – volume: 1 start-page: 2155 year: 2011 end-page: 2174 ident: CR2 article-title: Ca2+-activated Cl- channels publication-title: Compr. Physiol. doi: 10.1002/cphy.c110017 – volume: 25 start-page: 919 year: 2012 end-page: 929 ident: CR24 article-title: DOG1: a novel marker of salivary acinar and intercalated duct differentiation publication-title: Mod. Pathol. doi: 10.1038/modpathol.2012.57 – volume: 13 start-page: 2717 year: 2007 end-page: 2721 ident: CR19 article-title: TTYH2, a human homologue of the Drosophila melanogaster gene tweety, is up-regulated in colon carcinoma and involved in cell proliferation and cell aggregation publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v13.i19.2717 – volume: 12 start-page: 257 year: 1999 end-page: 265 ident: CR11 article-title: Influence of ion channel blockers on proliferation and free intracellular Ca2+ concentration of human keratinocytes publication-title: Skin Pharmacol. Appl. Skin Physiol. doi: 10.1159/000066250 – volume: 9 start-page: 746 year: 2018 ident: CR26 article-title: Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0768-6 – volume: 17 start-page: 557 year: 2020 end-page: 588 ident: CR1 article-title: Cholangiocarcinoma 2020: the next horizon in mechanisms and management publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0310-z – volume: 17 start-page: 38 year: 2015 ident: 642_CR12 publication-title: Gene Expr. Patterns doi: 10.1016/j.gep.2014.12.002 – volume: 31 start-page: 2237 year: 2012 ident: 642_CR22 publication-title: Oncogene doi: 10.1038/onc.2011.392 – volume: 72 start-page: 3270 year: 2012 ident: 642_CR6 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-0475-T – volume: 232 start-page: 3261 year: 2017 ident: 642_CR30 publication-title: J. Cell. Physiol. doi: 10.1002/jcp.25797 – volume: 164 start-page: 1015 year: 2016 ident: 642_CR29 publication-title: Cell doi: 10.1016/j.cell.2016.01.009 – volume: 516 start-page: 521 year: 2019 ident: 642_CR20 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2019.06.047 – volume: 455 start-page: 1210 year: 2008 ident: 642_CR4 publication-title: Nature doi: 10.1038/nature07313 – volume: 25 start-page: 1145 year: 2020 ident: 642_CR8 publication-title: Int. J. Clin. Oncol. doi: 10.1007/s10147-020-01653-6 – volume: 115 start-page: 1183 year: 2010 ident: 642_CR15 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2010.07023.x – volume: 38 start-page: 5500 year: 2019 ident: 642_CR32 publication-title: Oncogene doi: 10.1038/s41388-019-0806-6 – volume: 1 start-page: 2155 year: 2011 ident: 642_CR2 publication-title: Compr. Physiol. doi: 10.1002/cphy.c110017 – volume: 16 start-page: 152 year: 2017 ident: 642_CR3 publication-title: Mol. Cancer doi: 10.1186/s12943-017-0720-x – ident: 642_CR17 doi: 10.15252/embr.201745472 – volume: 77 start-page: 200 year: 2001 ident: 642_CR18 publication-title: Genomics doi: 10.1006/geno.2001.6629 – volume: 9 start-page: 746 year: 2018 ident: 642_CR26 publication-title: Cell Death Dis. doi: 10.1038/s41419-018-0768-6 – volume: 100 start-page: 693 year: 2007 ident: 642_CR16 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2006.04237.x – volume: 17 start-page: 557 year: 2020 ident: 642_CR1 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-020-0310-z – ident: 642_CR21 doi: 10.3390/jcm8111762 – volume: 309 start-page: 291 year: 2003 ident: 642_CR10 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.07.004 – volume: 46 start-page: 39 year: 2014 ident: 642_CR14 publication-title: Nat. Genet. doi: 10.1038/ng.2849 – ident: 642_CR27 doi: 10.1016/j.cell.2016.06.028 – volume: 37 start-page: 6837 year: 2017 ident: 642_CR13 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3532-16.2017 – volume: 25 start-page: 919 year: 2012 ident: 642_CR24 publication-title: Mod. Pathol. doi: 10.1038/modpathol.2012.57 – volume: 164 start-page: 840 year: 2016 ident: 642_CR28 publication-title: Cell doi: 10.1016/j.cell.2016.02.024 – volume: 85 start-page: 1061 year: 2005 ident: 642_CR9 publication-title: Physiol. Rev. doi: 10.1152/physrev.00016.2004 – volume: 165 start-page: 107 year: 2004 ident: 642_CR23 publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63279-8 – volume: 36 start-page: 29 year: 2017 ident: 642_CR31 publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-017-0499-z – volume: 1 start-page: 22 year: 2004 ident: 642_CR5 publication-title: Proc. Am. Thorac. Soc. doi: 10.1513/pats.2306010 – volume: 15 start-page: 38 year: 2017 ident: 642_CR25 publication-title: Cell Commun. Signal doi: 10.1186/s12964-017-0192-z – volume: 13 start-page: 2717 year: 2007 ident: 642_CR19 publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v13.i19.2717 – volume: 12 start-page: 257 year: 1999 ident: 642_CR11 publication-title: Skin Pharmacol. Appl. Skin Physiol. doi: 10.1159/000066250 – volume: 25 start-page: 1821 year: 2006 ident: 642_CR7 publication-title: Oncogene doi: 10.1038/sj.onc.1209203 |
SSID | ssj0000461656 |
Score | 2.4144268 |
Snippet | Purpose
Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the... Cholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the family of... PurposeCholangiocarcinoma (CCA) is a highly invasive malignant tumor originating from the bile duct epithelium. Tweety homolog 3 (TTYH3) is a member of the... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1351 |
SubjectTerms | Animals Apoptosis Apoptosis - genetics beta Catenin - metabolism Bile Duct Neoplasms - metabolism Bile ducts Bile Ducts, Intrahepatic - metabolism Bile Ducts, Intrahepatic - pathology Biomedical and Life Sciences Biomedicine Calcium channels Calcium chloride Cancer Research Cell culture Cell Line, Tumor Cell Movement - genetics Cell proliferation Cell Proliferation - genetics Chloride channels (calcium-gated) Chloride Channels - genetics Cholangiocarcinoma Cholangiocarcinoma - metabolism CpG islands Deoxyribonucleic acid DNA DNA methylation E-cadherin Epithelial-Mesenchymal Transition - genetics Epithelium Gene expression Gene Expression Regulation, Neoplastic Humans Mesenchyme Metastases mRNA N-Cadherin Oncology Original Article Pathology Signal transduction Tumors Up-Regulation - genetics Vimentin Wnt protein Wnt Signaling Pathway Xenografts β-Catenin |
Title | Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma |
URI | https://link.springer.com/article/10.1007/s13402-021-00642-9 https://www.ncbi.nlm.nih.gov/pubmed/34796468 https://www.proquest.com/docview/2607325729 https://www.proquest.com/docview/2599183871 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZoKyQuiP8ulJWRuIFFYzv2-rhataxA4rQr2lPkv9BIXSfapIc-Bq_Cg_BMjJ1kV6iAxDV2nMgz9nxjfzOD0NuMas-tZKS0VhLOhCY6l4aYCB9sVkqvU7bPL2K55p8u8oshKKwd2e7jlWTaqffBboxHtiwF9zeiZqIO0FEefXfQ4jWd705WYgpxkcq2Uhpz9AHAHqJl_jzM7xbpDsy8c0WaLM_5I_RwgIx43sv4MbrnwxN0vy8iefsUfV83276gPEwxrku8Wl0uGW4Sz8632Dcx7OIa9Ix0NdnEaCN7dbuBEbtopxJlCw_levDX0H34-YNEmlSoAo7sDh0D1rEODlfhqjJV12Ld1E1Xt1ULj3DyjsO3Cozi1lah3uhnaH1-tlosyVBogVgm844IgGnSlQB_FHX21DmjjCpzocG8w6Q5Uc6g0ebcGjtTsOy9ZC4z6pQqLXJJ2XN0GOrgjxGmVGuqM6GcENx4psuMOcktzbgBNGkmKBsnu7BDFvJYDOO62OdPjgIqQEBFElChJujd7p2mz8Hxz94nowyLYT22BXhtksHuRKH5za4ZVlK8HtHB1zfQJwesPGPgQU7Qi172u8_FeFvBxWyC3o_KsB_87__y8v-6v0IPaFTMxJY5QYfd9sa_BszTmSk6mn-8_Hw2RQcLsZgmhf8FJ3T66g |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELagCMEF8c9CASNxA6uN7djrI1pRLVB62hXlFNmO00bqOtEmPfQxeBUehGdixsluBQUkrrHjRJ5x5pvMzDeEvM64DdJrwSrvNZNCWWZz7ZhD-OCzSgeb2D6P1HwpPx7nxyNNDtbC_Ba_3-syITFHloPTi1iZmevkhgRPGdP3Zmq2_Z-CxOEqNWvlHJn5AFaPNTJ_XuZXO3QFXF4JjCZ7c3CX3BmBIn03SPYeuRbifXJzaB158YB8W7broY08bCxtKrpYfJ0L2qbsutDR0GKxxRloF-sbtsIaI396sYIVe7ROKVGLjk166JfY7_34zjA5KtaRYk6HxTJ1amNJ63hau7rvqG2btm-6uoNLNPnE8aQGU7j2dWxW9iFZHrxfzOZsbK_AvNB5zxSAM11WAHoML_1-WTrjTJUrC0YdNq1U1RQGfS6981MDhz1oUWbO7HNjVa65eER2YhPDE0I5t5bbTJlSKemCsFUmSi09z6QDDOkmJNtsduFH7nFsgXFWXLImo4AKEFCRBFSYCXmzvacdmDf-OXt3I8NiPIVdAb6aFvBN4jD8ajsM5weDIjaG5hzm5ICQpwL8xgl5PMh--zisslVSTSfk7UYZLhf_-7s8_b_pL8mt-eLzYXH44ejTM3Kbo5KmfJldstOvz8NzQD29e5HU_SfvFfdL |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgKxAX3o-lBYzEDdw2tmNvjhWwLBRVHHZFe4r8Co3oOtEmeyj_gr_SH9Lf1HEeu0ABCXGNHcePseebeOYbhF5EVDluJCOZMZJwJhRRsdREB_hgokw61bB9HojJjH84jA9_iOJvvN37K8k2piGwNPl6p7TZzjrwjfHgOUvBFA4ImiRX0QYP3HYDtLH37mh__Z8lEIqLJokrpYGxD-B2Fzvz-4Z-1k-XQOelC9NGD41vIdWPoHU_-bq9rPW2-fYLueP_DPE2utmBVLzXStUddMX5u-ham7by9B76PisXbQp7WFRcZHg6PZowXDaefa7CrgyBHicg2aQuyDzEN5nj0zm0WAfN2DiJ4S5BEP4MPTo_I8Exy-ceB38SFULksfIW5_4413ldYVUWZV1UeQWPcGOP-y85qOGFyX0xV_fRbPx2-npCutQOxDAZ10QAMJQ2A8CVUGt2rdWJTrJYKAAUMHwrshEUmpgbbUYJHDROMhvpZJcmSsSSsgdo4AvvHiFMqVJURSKxQnDtmMoiZiU3NOIa8Kseoqhf0NR0vOch_cZJumZsDlOdwlSnzVSnyRC9XL1Ttqwff6291ctJ2p0AVQp2omRwHlIofr4qhr0bLmSUd8US6sSAzkcMbNYhetjK1-pzIcJXcDEaole9rKwb_3NfHv9b9Wfo-qc34_Tj-4P9TXSDBmlrXHW20KBeLN0TAFy1ftrtqQvmQiFJ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+TTYH3+promotes+epithelial-to-mesenchymal+transition+through+Wnt%2F%CE%B2-catenin+signaling+and+inhibits+apoptosis+in+cholangiocarcinoma&rft.jtitle=Cellular+oncology+%28Dordrecht%29&rft.au=Xue%2C+Weijie&rft.au=Dong%2C+Bingzi&rft.au=Zhao%2C+Yanjie&rft.au=Wang%2C+Yixiu&rft.date=2021-12-01&rft.pub=Springer+Netherlands&rft.issn=2211-3428&rft.eissn=2211-3436&rft.volume=44&rft.issue=6&rft.spage=1351&rft.epage=1361&rft_id=info:doi/10.1007%2Fs13402-021-00642-9&rft.externalDocID=10_1007_s13402_021_00642_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3428&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3428&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3428&client=summon |